General
Preferred name
Ambenonium chloride
Synonyms
Ambenonium dichloride ()
Mytelase ()
P&D ID
PD022006
CAS
115-79-7
52022-31-8
Tags
available
drug
Drug Status
approved
Max Phase
Phase 4
First approval
1956
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
(Tocris Bioactive Compound Library)
DESCRIPTION
Cholinesterase inhibitor
(Tocriscreen Total)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
ChEMBL Approved Drugs
ChEMBL Drugs
DrugMatrix
Tocris Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
16
Molecular Weight
606.21
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
14
Ring Count
2
Aromatic Ring Count
2
cLogP
-1.35
TPSA
58.2
Fraction CSP3
0.5
Chiral centers
0.0
Largest ring
6.0
QED
0.21
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Primary Target
Cholinesterases
MOA
Inhibitor
Source data
